
The global gene therapy market is expected to reach $13 billion by 2024 as new treatment options target cancers and other diseases.
Now, a team of scientists from Purdue University and other research institutions around the world have come together to better understand the growing number of worldwide patented innovations available for gene therapy treatment. They specifically focus on nonviral methods, which use synthetic or natural compounds or physical forces to deliver materials generally less toxic than their viral counterparts into the therapy treatments.
Read the full story at Novel techniques for mining patented gene therapies offer promising treatment options for cancers, other diseases